Stockscreener 앱 받기
11.61
1.31%
0.125
전일 마감가:
$11.48
열려 있는:
$11.57
하루 거래량:
508.71K
Relative Volume:
0.40
시가총액:
$1.13B
수익:
-
순이익/손실:
$-137.25M
주가수익비율:
-6.1402
EPS:
-1.89
순현금흐름:
$-121.97M
1주 성능:
-5.06%
1개월 성능:
-7.70%
6개월 성능:
+98.13%
1년 성능:
+27.52%
1일 변동 폭
$11.02
$11.70
1주일 범위
$11.02
$12.71
52주 변동 폭
$3.8951
$14.93
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
명칭
Oric Pharmaceuticals Inc
전화
(650) 388-5600
주소
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
ORIC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
11.60 | 1.12B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.25 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.72 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.20 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.42 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.38 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | Evercore ISI | Outperform |
| 2025-11-18 | 개시 | Wolfe Research | Peer Perform |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-07-08 | 개시 | Ladenburg Thalmann | Buy |
| 2024-10-31 | 개시 | Wells Fargo | Overweight |
| 2024-09-06 | 개시 | Stifel | Buy |
| 2024-02-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-09-22 | 개시 | Wedbush | Outperform |
| 2023-03-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Perform |
| 2022-04-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-03-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-08-13 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Citigroup | Neutral |
| 2020-05-19 | 개시 | Guggenheim | Buy |
| 2020-05-19 | 개시 | JP Morgan | Overweight |
| 2020-05-19 | 개시 | Jefferies | Buy |
모두보기
Oric Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated at Evercore ISI - MarketBeat
Evercore ISI Group Initiates Coverage of ORIC Pharmaceuticals (ORIC) with Outperform Recommendation - MSN
Oric Pharmaceuticals (ORIC) Upgraded to Buy: Here's What You Should Know - MSN
This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
ORIC Pharmaceuticals (ORIC) Initiates Coverage with Outperform Rating | ORIC Stock News - GuruFocus
Is ORIC Pharmaceuticals Inc. (4TZ) stock positioned for secular growthChart Signals & High Win Rate Trade Tips - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock attracts HNW investorsEarnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Is ORIC Pharmaceuticals Inc. (4TZ) stock attractive for growth funds2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Can ORIC Pharmaceuticals Inc. stock resist sector downturnsJuly 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
Is ORIC Pharmaceuticals Inc. stock undervalued vs historical averagesEarnings Miss & Consistent Growth Stock Picks - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock benefits from AI revolutionQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Will ORIC Pharmaceuticals Inc. stock maintain momentum in 2025July 2025 Trends & Stepwise Trade Signal Guides - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
ORIC: ORIC-944 demonstrates high ctDNA clearance and safety, supporting pivotal trials and market expansion - TradingView
Wolfe Research Initiates Coverage on Oric Pharmaceuticals (NASDAQ:ORIC) - MarketBeat
Why institutional investors increase stakes in ORIC Pharmaceuticals Inc. (4TZ) stock2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
The Technical Signals Behind (ORIC) That Institutions Follow - news.stocktradersdaily.com
Why ORIC Pharmaceuticals Inc. stock could see breakout soon2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Is this a good reentry point in ORIC Pharmaceuticals Inc.2025 Historical Comparison & Stock Market Timing Techniques - newser.com
Analyst Initiation: Wolfe Research Rates ORIC Pharmaceuticals as 'Peer Perform' | ORIC Stock News - GuruFocus
JP Morgan Raises ORIC Pharmaceuticals (ORIC) Price Target to $20 - GuruFocus
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
Can you recover from losses in ORIC Pharmaceuticals Inc.Weekly Volume Report & Entry and Exit Point Strategies - newser.com
Wolfe Research initiates coverage on ORIC Pharmaceuticals stock with Peerperform rating - Investing.com Canada
Citigroup Raises ORIC Pharmaceuticals Price Target to $16 | ORIC Stock News - GuruFocus
Relative strength of ORIC Pharmaceuticals Inc. in sector analysisJuly 2025 Market Mood & Target Return Focused Picks - newser.com
ORIC Pharma Surges Ahead With ORIC-944 And Enozertinib Data Momentum - RTTNews
Oric Pharmaceuticals' (ORIC) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat
Why analysts recommend ORIC Pharmaceuticals Inc. (4TZ) stockWeekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Oric Pharmaceuticals’ 2025 Restructuring: Potential Risks and Financial Implications - TipRanks
Wells Fargo & Company Lowers Oric Pharmaceuticals (NASDAQ:ORIC) Price Target to $19.00 - MarketBeat
Oric Pharmaceuticals Inc (ORIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Oric Pharmaceuticals Inc 주식 (ORIC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer |
Oct 06 '25 |
Sale |
14.52 |
11,000 |
159,719 |
48,317 |
| Chacko Jacob | PRESIDENT AND CEO |
Oct 06 '25 |
Sale |
12.32 |
37,461 |
461,520 |
531,419 |
1.75%
0.74%
자본화:
|
볼륨(24시간):